Cargando…

Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study

INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation int...

Descripción completa

Detalles Bibliográficos
Autores principales: Prins, Jelmer R, Holvast, Floor, van ’t Hooft, Janneke, Bos, Arend F, Ganzevoort, Jan Willem, Scherjon, Sicco A, Robertson, Sarah A, Gordijn, Sanne J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078247/
https://www.ncbi.nlm.nih.gov/pubmed/30082354
http://dx.doi.org/10.1136/bmjopen-2018-021619
_version_ 1783345058474360832
author Prins, Jelmer R
Holvast, Floor
van ’t Hooft, Janneke
Bos, Arend F
Ganzevoort, Jan Willem
Scherjon, Sicco A
Robertson, Sarah A
Gordijn, Sanne J
author_facet Prins, Jelmer R
Holvast, Floor
van ’t Hooft, Janneke
Bos, Arend F
Ganzevoort, Jan Willem
Scherjon, Sicco A
Robertson, Sarah A
Gordijn, Sanne J
author_sort Prins, Jelmer R
collection PubMed
description INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation interventions as preventive or therapeutic strategies for pregnancy complications holds promise. Several studies sought to evaluate the safety and effectiveness of various approaches. However, a limitation is the high variability in clinical and immune outcomes that are reported. We, therefore, aim to develop a core outcome set for application to studies of immune modulation in pregnancy (COSIMPREG). METHODS AND ANALYSIS: We will use a stepwise approach to develop a COSIMPREG. First, we will perform a systematic review to identify reported outcomes. For this review, Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. Second, we will use the Delphi method to develop a preliminary COSIMPREG. In three rounds, the outcomes of the systematic review will be scored. A panel comprising experts from relevant disciplines and diverse geographical locations will be assembled until a sufficient quality of the panel is reached. We will use predefined decision rules for outcomes. After each round outcomes, including scores, will be returned to the panel for further refinement. The outcomes not excluded after the third round will be taken to a consensus meeting. In this meeting, experts from all relevant disciplines will discuss and finalise the COSIMPREG. ETHICS AND DISSEMINATION: For this study ethical approval is not required. The systematic review will be published in an appropriate open access reproductive immunology journal. Once the COSIMPREG is finalised, it will be published in an open access reproductive immunology journal, and disseminated at appropriate international meetings, as well as through relevant research and scientific societies. Experts involved in the Delphi study will be asked to give informed consent.
format Online
Article
Text
id pubmed-6078247
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60782472018-08-09 Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study Prins, Jelmer R Holvast, Floor van ’t Hooft, Janneke Bos, Arend F Ganzevoort, Jan Willem Scherjon, Sicco A Robertson, Sarah A Gordijn, Sanne J BMJ Open Obstetrics and Gynaecology INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation interventions as preventive or therapeutic strategies for pregnancy complications holds promise. Several studies sought to evaluate the safety and effectiveness of various approaches. However, a limitation is the high variability in clinical and immune outcomes that are reported. We, therefore, aim to develop a core outcome set for application to studies of immune modulation in pregnancy (COSIMPREG). METHODS AND ANALYSIS: We will use a stepwise approach to develop a COSIMPREG. First, we will perform a systematic review to identify reported outcomes. For this review, Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. Second, we will use the Delphi method to develop a preliminary COSIMPREG. In three rounds, the outcomes of the systematic review will be scored. A panel comprising experts from relevant disciplines and diverse geographical locations will be assembled until a sufficient quality of the panel is reached. We will use predefined decision rules for outcomes. After each round outcomes, including scores, will be returned to the panel for further refinement. The outcomes not excluded after the third round will be taken to a consensus meeting. In this meeting, experts from all relevant disciplines will discuss and finalise the COSIMPREG. ETHICS AND DISSEMINATION: For this study ethical approval is not required. The systematic review will be published in an appropriate open access reproductive immunology journal. Once the COSIMPREG is finalised, it will be published in an open access reproductive immunology journal, and disseminated at appropriate international meetings, as well as through relevant research and scientific societies. Experts involved in the Delphi study will be asked to give informed consent. BMJ Publishing Group 2018-08-05 /pmc/articles/PMC6078247/ /pubmed/30082354 http://dx.doi.org/10.1136/bmjopen-2018-021619 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Obstetrics and Gynaecology
Prins, Jelmer R
Holvast, Floor
van ’t Hooft, Janneke
Bos, Arend F
Ganzevoort, Jan Willem
Scherjon, Sicco A
Robertson, Sarah A
Gordijn, Sanne J
Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title_full Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title_fullStr Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title_full_unstemmed Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title_short Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
title_sort development of a core outcome set for immunomodulation in pregnancy (cosimpreg): a protocol for a systematic review and delphi study
topic Obstetrics and Gynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078247/
https://www.ncbi.nlm.nih.gov/pubmed/30082354
http://dx.doi.org/10.1136/bmjopen-2018-021619
work_keys_str_mv AT prinsjelmerr developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT holvastfloor developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT vanthooftjanneke developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT bosarendf developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT ganzevoortjanwillem developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT scherjonsiccoa developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT robertsonsaraha developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy
AT gordijnsannej developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy